A new three-in-one livestock vaccine launched in Kenya offers farmers protection against major diseases, reducing costs, improving herd health and strengthening agricultural resilience across the region.
A novel combination vaccine has been introduced in Kenya, marking a significant step forward in livestock health and farmer support. The vaccine protects sheep and goats against three of the most common and devastating diseases — Contagious Caprine Pleuropneumonia (CCPP), Sheep and Goat Pox (SGP), and Peste des Petits Ruminants (PPR).
Unveiled at the 60th Kenya Veterinary Association Congress in Diani, the vaccine is the first of its kind to offer triple protection in a single dose.
Livestock diseases continue to place a heavy burden on farmers, particularly in pastoral communities. CCPP alone can cost an average farmer up to KSh 260,000 annually, while SGP can affect as much as 80% of a herd. PPR remains one of the most lethal diseases, with mortality rates of up to 70%.
By combining protection into one vaccine, farmers can reduce costs, simplify vaccination schedules and improve overall herd survival.
The vaccine was developed by Jordan Bio-Industries Center (JOVAC) under an initiative led by the Global Alliance for Livestock Veterinary Medicines (GALVmed). The programme forms part of the Veterinary Innovations Transforming Animal Health and Livelihoods (VITAL) project, now in its second phase.
“Combination vaccines are the veterinarian’s multitool, providing protection against multiple diseases in one shot to save time, money and resources,” said Dr Lois Muraguri, CEO of GALVmed.
The product incorporates advanced vaccine technology, including a novel stabiliser to improve shelf life and a live vaccine component for CCPP, enhancing effectiveness compared to traditional approaches.
The vaccine was administered for the first time at a farm in Kwale County on April 25, aligning with World Veterinary Day — a milestone that highlights the growing role of veterinary innovation in supporting food security and livelihoods.
The broader VITAL project has also produced additional combination vaccines currently undergoing regulatory review, including solutions targeting other major livestock diseases such as CBPP, Lumpy Skin Disease and Rift Valley Fever.
Livestock remains a critical economic pillar in Kenya and across East Africa. Diseases such as Rift Valley Fever and Contagious Bovine Pleuropneumonia alone cost the Kenyan economy billions annually.
By making vaccination more accessible and efficient, combination vaccines are expected to improve food security, protect farmer incomes and strengthen rural economies.
“The VITAL project is demonstrating how public and private sectors can work together to deliver vaccines that make disease prevention easier and more cost-effective for farmers,” said Dr Samson Muchelule, CEO of the Kenya Veterinary Association.
With innovation, partnership and accessibility aligned, the future of livestock health in Africa is becoming more resilient — one vaccine at a time.
